Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Neurosci Behav Physiol
2002 Jan 01;323:283-91. doi: 10.1023/a:1015014408089.
Show Gene links
Show Anatomy links
Analysis of ligand-receptor interactions from the molecular level to the whole-body level.
Manukhin BN.
???displayArticle.abstract???
A system for the quantitative analysis of ligand-receptor interactions is presented, based on models of different levels of complexity. For two pools of receptors, binding of a radioactive ligand is described by b = [(Bml x A(nl))/(K(nl)dl + A(nl))] + [(Bm2 x A(n2))/(Kn2(d2) + A(n2))], (1) where b is the number of bound receptors at a ligand concentration [A], Bml and Bm2 are the receptor concentrations. Kdl and Kd2 are dissociation constants for the ligand-receptor complex, and n1 and n2 are Hill coefficients. The magnitude of the physiological response for a system consisting of two discrete pools of receptors with different affinities is given by p = [(Pm x A(nl))/(EC50(nl) + A(nl))] + [(Pm2 x A(n2)/(EC50(n2)2 + A(n2))], (2) where p is the magnitude of the response to an agonist (or antagonist) at concentration [A], Pml and Pm2 are the maximal magnitudes of the responses for the individual pools of receptors, EC50(1) and EC50(2) are the agonist concentrations giving responses of magnitudes Pm1/2 and Pm2/2, and n1 and n2 are Hill coefficients. The parameters of these equations show: the number of pools of receptors with different affinities for the ligand (Kd or EC50), the number of active receptors (Bmax) or the magnitudes of the maximal response (Pmax), and the numbers of ligand molecules binding with the receptor (n, the Hill coefficient). E is the efficiency (E = Bmax/2Kd, or E = Pmax/2EC50) and gives the overall characteristics of the activity of the effector system. This method of analysis can be applied to any biological reactions whose results can be presented quantitatively.
Agneter,
The slope parameter of concentration-response curves used as a touchstone for the existence of spare receptors.
1997, Pubmed
Agneter,
The slope parameter of concentration-response curves used as a touchstone for the existence of spare receptors.
1997,
Pubmed Anhäupl,
Kinetic and equilibrium studies of (-)125iodocyanopindolol binding to beta-adrenoceptors on human lymphocytes: evidence for the existence of two classes of binding sites.
1988,
Pubmed Barlow,
Antagonist inhibition curves and the measurement of dissociation constants.
1997,
Pubmed Boĭko,
[Characteristics of the stimulatory adrenergic reaction of isolated chick embryo amnion].
1997,
Pubmed Buchman,
A theoretical experimental method to determine the locus of desensitization.
1999,
Pubmed Chidiac,
Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity.
1997,
Pubmed Dunn,
Agonist binding to the Torpedo acetylcholine receptor. 1. Complexities revealed by dissociation kinetics.
1997,
Pubmed Feldman,
Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting.
1972,
Pubmed Fowler,
Evidence for cooperative binding of (-)Isoproterenol to rat brain beta1-adrenergic receptors.
1999,
Pubmed Haen,
Revised radioreceptor assay for beta 2-adrenoceptors expressed on peripheral mononuclear leukocytes.
1991,
Pubmed Herz,
Molecular approaches to receptors as targets for drug discovery.
1997,
Pubmed Järv,
A model of non-exclusive binding of agonist and antagonist on G-protein coupled receptors.
1995,
Pubmed Klotz,
Properties of graphical representations of multiple classes of binding sites.
1971,
Pubmed Lazareno,
Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
1995,
Pubmed Ledneva,
[The effect of acetylcholine and serotonin on the adrenergic reaction of the rat small intestine].
1990,
Pubmed Manukhin,
An approach to analysis of radiolabeled ligand interactions with specific receptors.
1999,
Pubmed Manukhin,
[Quantitative analysis of ligand-receptor interactions in physiological experiments].
1998,
Pubmed
,
Echinobase Manukhin,
[Kinetic analysis of smooth muscle reaction to acetylcholine].
1987,
Pubmed
,
Echinobase Molinoff,
Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypes.
1981,
Pubmed Munson,
Ligand: a versatile computerized approach for characterization of ligand-binding systems.
1980,
Pubmed Nesterova,
[The characteristics of the adrenergic reaction of the portal vein in the rat liver].
1990,
Pubmed Ongun Onaran,
Ligand efficacy and affinity in an interacting 7TM receptor model.
1999,
Pubmed Prince,
Acetylcholine and epibatidine binding to muscle acetylcholine receptors distinguish between concerted and uncoupled models.
1999,
Pubmed Sandnes,
Modes of determining beta-adrenoceptor number in human mononuclear leucocytes.
1987,
Pubmed Takeda,
Alpha-1 adrenoceptor subtypes (high, low) in human benign prostatic hypertrophy tissue according to the affinities for prazosin.
1997,
Pubmed Van der Graaf,
Analysis of asymmetry of agonist concentration-effect curves.
1999,
Pubmed Vivas,
Use of the operational model of agonism and [3H]prazosin binding to assess altered responsiveness of alpha1-adrenoceptors in the vas deferens of spontaneously hypertensive rat.
1997,
Pubmed Wreggett,
Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors.
1995,
Pubmed
